| Full name | Shimon Sakaguchi |
|---|---|
| Born | 19 January 1951 |
| Place of birth | Shiga Prefecture, Japan |
| Nationality | Japanese |
| Education | MD (1976), PhD (1982), Kyoto University; postdoctoral research at Johns Hopkins & Stanford |
| Current role | Distinguished Professor, Immunology (Osaka University) |
| Major contribution | Discovery of regulatory T cells (Tregs) and demonstration of their role in peripheral immune tolerance |
| Impact | New paths for treating autoimmune disease, improving cancer immunotherapy, and reducing transplant complications |
| Recent news | Co-recipient of the 2025 Nobel Prize in Physiology or Medicine (awarded Oct 2025) |
| Official links | Nobel Prize 2025 — Medicine • Osaka University |
| Full name | Mary E. Brunkow |
|---|---|
| Current role | Program Manager, Institute for Systems Biology (Seattle) |
| Major contribution | Identification of Foxp3 mutation in mice and demonstration of its role in regulatory T cell dysfunction and autoimmunity |
| Key discovery | Link between Foxp3 mutation and severe autoimmune disease phenotypes (foundation for understanding IPEX syndrome) |
| Impact | Helped translate Treg biology into clinical and therapeutic research for autoimmune conditions |
| Recent news | Co-recipient of the 2025 Nobel Prize in Physiology or Medicine (awarded Oct 2025) |
| Notes | Personal details (birthdate, family, public net worth) are limited in public sources; professional contributions are well documented. |
| Official links | Nobel Prize 2025 — Medicine • Institute for Systems Biology |
| Full name | Fred Ramsdell |
|---|---|
| Current role | Scientific Adviser & co-researcher (Sonoma Biotherapeutics / biotech sector) |
| Major contribution | Co-identification of the Foxp3 gene mutation in mice and linking it to human autoimmune disease (IPEX) |
| Impact | Provided molecular explanation for self-tolerance failure and advanced potential Treg-focused treatments |
| Recent news | Co-recipient of the 2025 Nobel Prize in Physiology or Medicine (awarded Oct 2025) |
| Notes | Public profiles for family, birthdate, or net worth are limited; professional affiliations and publications provide the core public record. |
| Official links | Nobel Prize 2025 — Medicine • Sonoma Biotherapeutics |
In 2025, the Nobel Prize in Physiology or Medicine was awarded to Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi for their discoveries in peripheral immune tolerance, specifically how regulatory T cells keep our immune system in check.
Their work has deep implications for treating autoimmune diseases, improving cancer therapies, and enhancing outcomes in organ transplants.
Shimon Sakaguchi - The Japanese Pioneer
Early Life, Education & Career
- Full Name: Shimon Sakaguchi
- Date of Birth: January 19, 1951
- Place of Birth: Shiga Prefecture, Japan
- Education: M.D. (1976) and Ph.D. (1982) from Kyoto University
- He conducted postdoctoral research at Johns Hopkins and Stanford.
- Later, he held faculty and leadership roles in Kyoto University, Osaka University, and Tokyo institutions.
- He is a Distinguished Professor at Osaka University and has held affiliated positions in immunology institutions.
Discovery & Contributions
- In 1995, Sakaguchi first identified regulatory T cells (Tregs), a class of immune cells that restrain the immune system from attacking the body.
- He proposed that immune regulation occurs not just centrally (in the thymus) but also peripherally (outside the thymus).
- He linked Treg behavior to gene regulation, particularly focusing on how the Foxp3 gene influences their development and function.
Recent Roles & Recognition
- Sakaguchi continues leading research at Osaka University’s Immunology Frontier Research Center.
- He received the 2025 Nobel Prize alongside Brunkow and Ramsdell.
Mary E. Brunkow & Fred Ramsdell - Bridging the Gene to Function Gap
Mary E. Brunkow
- Role & Position (2025): Senior Program Manager, Institute for Systems Biology, Seattle.
- She worked on mutant mice showing autoimmune disease phenotypes and helped uncover how mutations in Foxp3 lead to self-attack of immune cells.
- Very limited public info on her early life, family, or net worth is available.
Fred Ramsdell
- Current Role (2025): Scientific Adviser for Sonoma Biotherapeutics, San Francisco.
- He collaborated with Brunkow in the early 2000s to identify the Foxp3 mutation and link it to human autoimmune disease, notably IPEX syndrome.
- Publicly available data on his personal life, family, or wealth is scarce.
Key Achievements & Scientific Discoveries
Regulatory T Cells (Tregs) & “Immune Security”
The trio’s major contribution is clarifying how the immune system regulates itself to avoid attacking healthy tissues. Their work gave rise to the concept of peripheral immune tolerance.
Foxp3 Gene & Autoimmunity
Brunkow and Ramsdell’s discovery that defects in Foxp3 disrupt regulatory T cell function explains severe autoimmune conditions like IPEX syndrome in humans.
Sakaguchi later linked his Treg discovery to Foxp3’s regulatory role.
Impact on Medicine & Therapies
Their insights are opening new paths for therapies in autoimmune disorders, cancer immunotherapy, and improving outcomes in stem cell / organ transplantation.
Recent News & Context
- The 2025 Nobel Prize announcement was made in Stockholm, Sweden.
- The laureates will share a prize sum of 11 million Swedish kronor (USD 1.2 million).
- Their award is already driving renewed interest in immunological research and clinical trials targeting Treg-based therapies.
Biography Snapshot - Table of Facts
| Field | Info |
|---|---|
| Shimon Sakaguchi | Japanese immunologist, born Jan 19, 1951; MD & PhD from Kyoto University; works at Osaka University |
| Mary E. Brunkow | Senior program manager, Institute for Systems Biology, Seattle |
| Fred Ramsdell | Scientific adviser, Sonoma Biotherapeutics, San Francisco |
| Major Discovery | Regulatory T cells & Foxp3 gene linking immune balance and autoimmunity |
| Awards | 2025 Nobel Prize in Medicine / Physiology |
| Prize Money | 11 million Swedish kronor (USD 1.2 million) |
| Recent Impact | Revival of Treg-based therapy research, immunology breakthroughs |
About the Author
Praise Graciebby is a content creator on The StarProfile, where she writes celebrity biographies, sports updates, gossip, and trending news. With a passion for entertainment and lifestyle journalism, Praise provides readers with simple, accurate, and up-to-date profiles of public figures worldwide.
0 Comments